With numerous approaches emerging that demonstrate genuinely viable efficacy in targeting RNA, the RNA- Targeted Drug Discovery Summit is the only industry and translational focused conference dedicated to advancing pioneering RNA targeted small molecule therapeutics.
Why You Should Attend the RNA- Targeted Drug Discovery Summit
Expand your knowledge of RNA structure, function & role in disease with insights from Beth Israel Deaconess Medical Center, University of North Carolina & Northwestern University
Successfully target RNA via interfering with RNA-protein interactions/ epitranscriptomics with insights from Storm Therapeutics, Accent Therapeutics & Gotham Therapeutics
Advance identification & validation of viable RNA target sites for therapeutic intervention with insights from Bristol-Myers Squibb, PTC Therapeutics & Merck
Overcome binding, selectivity & drug-like challenges of small molecules targeting RNA with insights from Pfizer, Novartis & Weill Cornell Medicine
Join the momentum to reverse the undruggable nature of RNA and seize the enormous therapeutic potential with R&D and strategic insights from Anima Biotech, Arrakis Therapeutics & Eli Lilly